EUCTR2015-004563-37-PL进行中（未招募）1 期
Study of the efficacy and safety of treatment with completely lyophilisedcultures of Lactobacillus crispatus - IP 174178 administered intravaginallyin the treatment of bacterial vaginosis. - IPR_GARDEFLORA_15-2
aboratoires IPRAD PHARMA0 个研究点目标入组 530 人开始时间: 2016年4月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 530
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Woman over 18 years old,
- •Patients with clinical symptoms suggestive of bacterial vaginosis, linked to an imbalance of vaginal flora, characterised by the presence of at least 3 of 4 of the following Amsel clinical criteria: uniform greyish vaginal discharge, characteristic odour of rotten fish caused by the spontaneous release of amine or during the potassium test or sniff test, vaginal pH greater than 4.5, presence of clue cells (at least 20%) during the vaginal secretions direct exam
- •Patient with negative pregnancy test at V1,
- •Patient using a contraceptive method considered effective by the investigator (excluding spermicides),
- •Patient having received all the information on the study and having voluntarily given her written informed consent,
- •Patient registered with social security or other social protection.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 530
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Presence of an existing gynaecological infection that may affect the evaluation of the trial treatment (severe dysplasia or cervical carcinoma in situ, invasive carcinoma, cervical intraepithelial neoplasia, squamous intraepithelial lesions etc.),
- •Patient having taken an antibiotic or antifungal treatment within 14 days prior to V1 (after administration by any route).
- •Patient unable to comply with the constraints of the protocol,
- •Patients having more than 12 days of menses per month,
- •Patient pregnant or breastfeeding,
- •Menopausal patient,
- •Patient with a known allergy to any of the active substances or to any of the excipients of the study products,
- •Patient with severe acute or chronic disease considered by the investigator as being incompatible with participation in this study, or with a serious infection that may endanger the life of the patient in the short term,
- •Immunosuppressed patient,
- •Patient with a previous illness that, according to the investigator, could compromise the results of the study or expose the patient to additional risk,
- •Patient with psychological or linguistic factors limiting the understanding and signature for the informed consent form,
- •Patient deprived of their liberty by court judgement or subject to guardianship,
- •Patient at risk of failing to follow the treatment (compliance problem),
- •Patient impossible to contact in an emergency.
- •Antibiotics or fungicides taken systemically during the month preceding the screening visit, excluding treatments for the bacterial vaginosis episode.
- •Use of local probiotics in the months preceding the screening visit.
- •Use of antiseptics in the months preceding the screening visit, excluding treatments for the bacterial vaginosis episode.
- •Use of prebiotics (acidifiers) during the two weeks preceding the screening visit.
- •Use of products containing topical oestrogen in the month before the screening visit.
研究者
相似试验
进行中（未招募）
1 期
Study of the efficacy and safety of Lcr Regenerans®_GynoCans.EUCTR2013-002480-26-PLBIOSE234
尚未招募
1 期
euroEPO – Type 2 Spinocerebellar Ataxia Phase I-IIType 2 Spinocerebellar AtaxiaRPCEC00000187Center of Molecular Immunology (CIM), CIMAB34
进行中（未招募）
不适用
Study on the effectiveness and safety of the treatment of hyponatremia due to inappropriate secretion of antidiuretic hormone (SIADH) with Tolvaptan vs fluid restriction in patients affected by pituitary disorders.EUCTR2012-004071-39-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
招募中
4 期
Clinical study on the effectiveness and safety of wound healing after low anal fistulaarchosyrinxITMCTR2024000059Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
进行中（未招募）
不适用
Clinical study of the safety and effectiveness of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) as fillers in the treatment of lip thinness and wrinkles around the mouthISRCTN30768206Sinclair Pharma68